Core Laboratories Nv Stock Beta

CLB Stock  USD 14.73  0.27  1.80%   
Core Laboratories NV fundamentals help investors to digest information that contributes to Core Laboratories' financial success or failures. It also enables traders to predict the movement of Core Stock. The fundamental analysis module provides a way to measure Core Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Core Laboratories stock.
Short Long Term Debt TotalTotal Assets
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Core Laboratories NV Company Beta Analysis

Core Laboratories' Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Beta

 = 

Covariance

Variance

More About Beta | All Equity Analysis

Current Core Laboratories Beta

    
  2.38  
Most of Core Laboratories' fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Core Laboratories NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Core Beta Driver Correlations

Understanding the fundamental principles of building solid financial models for Core Laboratories is extremely important. It helps to project a fair market value of Core Stock properly, considering its historical fundamentals such as Beta. Since Core Laboratories' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Core Laboratories' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Core Laboratories' interrelated accounts and indicators.
0.40.770.510.70.730.880.550.340.410.50.620.470.440.33-0.33-0.440.380.280.350.050.17-0.230.170.10.0
0.4-0.130.150.530.30.010.34-0.10.080.17-0.290.190.180.030.250.340.57-0.550.29-0.630.26-0.08-0.050.32-0.12
0.77-0.130.320.30.490.960.540.40.560.540.910.230.40.41-0.46-0.720.060.740.090.47-0.02-0.440.22-0.210.27
0.510.150.320.770.940.50.6-0.160.190.390.510.080.450.42-0.86-0.39-0.210.4-0.180.44-0.6-0.10.28-0.030.14
0.70.530.30.770.890.520.66-0.130.090.550.350.250.550.31-0.49-0.240.020.070.060.1-0.24-0.060.040.10.12
0.730.30.490.940.890.670.7-0.050.220.480.590.230.520.41-0.76-0.43-0.080.37-0.020.37-0.4-0.130.230.050.09
0.880.010.960.50.520.670.630.390.520.630.90.280.520.46-0.55-0.740.080.670.10.42-0.09-0.370.21-0.180.28
0.550.340.540.60.660.70.63-0.130.430.80.560.030.690.49-0.65-0.56-0.130.43-0.170.35-0.49-0.380.18-0.270.5
0.34-0.10.4-0.16-0.13-0.050.39-0.130.12-0.010.30.36-0.010.030.07-0.310.370.140.43-0.050.460.02-0.150.05-0.07
0.410.080.560.190.090.220.520.430.120.460.54-0.270.540.81-0.25-0.430.230.57-0.280.11-0.23-0.820.62-0.10.47
0.50.170.540.390.550.480.630.8-0.010.460.54-0.070.760.5-0.47-0.64-0.040.4-0.270.22-0.45-0.37-0.02-0.590.8
0.62-0.290.910.510.350.590.90.560.30.540.540.00.530.59-0.7-0.83-0.240.91-0.190.7-0.35-0.460.3-0.240.39
0.470.190.230.080.250.230.280.030.36-0.27-0.070.0-0.25-0.43-0.01-0.070.31-0.210.9-0.040.530.62-0.380.35-0.45
0.440.180.40.450.550.520.520.69-0.010.540.760.53-0.250.83-0.46-0.67-0.170.43-0.420.22-0.51-0.490.44-0.180.55
0.330.030.410.420.310.410.460.490.030.810.50.59-0.430.83-0.46-0.59-0.120.62-0.50.28-0.52-0.740.68-0.020.51
-0.330.25-0.46-0.86-0.49-0.76-0.55-0.650.07-0.25-0.47-0.7-0.01-0.46-0.460.650.47-0.710.29-0.770.750.14-0.250.27-0.36
-0.440.34-0.72-0.39-0.24-0.43-0.74-0.56-0.31-0.43-0.64-0.83-0.07-0.67-0.590.650.32-0.780.17-0.640.420.21-0.210.33-0.51
0.380.570.06-0.210.02-0.080.08-0.130.370.23-0.04-0.240.31-0.17-0.120.470.32-0.440.48-0.760.65-0.09-0.030.19-0.21
0.28-0.550.740.40.070.370.670.430.140.570.40.91-0.210.430.62-0.71-0.78-0.44-0.390.83-0.52-0.510.41-0.280.45
0.350.290.09-0.180.06-0.020.1-0.170.43-0.28-0.27-0.190.9-0.42-0.50.290.170.48-0.39-0.30.770.53-0.40.48-0.55
0.05-0.630.470.440.10.370.420.35-0.050.110.220.7-0.040.220.28-0.77-0.64-0.760.83-0.3-0.6-0.070.11-0.230.28
0.170.26-0.02-0.6-0.24-0.4-0.09-0.490.46-0.23-0.45-0.350.53-0.51-0.520.750.420.65-0.520.77-0.60.27-0.260.47-0.62
-0.23-0.08-0.44-0.1-0.06-0.13-0.37-0.380.02-0.82-0.37-0.460.62-0.49-0.740.140.21-0.09-0.510.53-0.070.27-0.640.18-0.44
0.17-0.050.220.280.040.230.210.18-0.150.62-0.020.3-0.380.440.68-0.25-0.21-0.030.41-0.40.11-0.26-0.640.22-0.09
0.10.32-0.21-0.030.10.05-0.18-0.270.05-0.1-0.59-0.240.35-0.18-0.020.270.330.19-0.280.48-0.230.470.180.22-0.72
0.0-0.120.270.140.120.090.280.5-0.070.470.80.39-0.450.550.51-0.36-0.51-0.210.45-0.550.28-0.62-0.44-0.09-0.72
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Competition

In accordance with the recently published financial statements, Core Laboratories NV has a Beta of 2.385. This is 40.29% higher than that of the Energy Equipment & Services sector and 31.77% higher than that of the Energy industry. The beta for all United States stocks is notably lower than that of the firm.

Core Beta Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Core Laboratories' direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Core Laboratories could also be used in its relative valuation, which is a method of valuing Core Laboratories by comparing valuation metrics of similar companies.
2.381.982.882.62100%
Core Laboratories is currently under evaluation in beta category among its peers.

Core Laboratories ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Core Laboratories' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Core Laboratories' managers, analysts, and investors.
61.7%
Environmental
Governance
Social

Core Laboratories Institutional Holders

Institutional Holdings refers to the ownership stake in Core Laboratories that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Core Laboratories' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Core Laboratories' value.
Shares
Dimensional Fund Advisors, Inc.2024-12-31
848 K
Btim Corp2024-12-31
617.3 K
Northern Trust Corp2024-12-31
577.8 K
Fred Alger Management, Llc2024-12-31
556.5 K
Charles Schwab Investment Management Inc2024-12-31
499.3 K
Bank Of New York Mellon Corp2024-12-31
450 K
Van Eck Associates Corporation2024-12-31
443.6 K
Gendell Jeffrey L2024-12-31
430.2 K
Ubs Group Ag2024-12-31
377.1 K
Ariel Investments, Llc2024-12-31
9.6 M
Blackrock Inc2024-12-31
7.9 M
As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Core Laboratories will likely underperform.

Core Fundamentals

Return On Equity0.13
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-4,000%-3,000%-2,000%-1,000%0%1,000%2,000%
Return On Asset0.0553
Profit Margin0.06 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-400%-200%0%200%
Operating Margin0.08 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%50%100%150%
Current Valuation863.39 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-311,000%2,000%3,000%4,000%
Shares Outstanding46.83 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-315%10%15%20%
Shares Owned By Insiders1.78 %
Shares Owned By Institutions98.22 %
Number Of Shares Shorted6.07 M
Price To Earning101.74 X
Price To Book2.79 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-5,000%-4,000%-3,000%-2,000%-1,000%0%1,000%
Price To Sales1.33 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31100%200%300%400%
Revenue523.85 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31200%400%600%800%1,000%1,200%
Gross Profit103.33 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%2,000%
EBITDA73.51 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-500%0%500%1,000%1,500%2,000%2,500%
Net Income32.15 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-2,000%0%2,000%4,000%6,000%
Cash And Equivalents15.43 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-20%-10%0%10%20%
Cash Per Share0.29 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31100%200%300%400%
Total Debt180.14 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%2,000%2,500%3,000%
Debt To Equity1.29 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-4,000%-3,000%-2,000%-1,000%0%1,000%
Current Ratio2.23 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%-80%-60%-40%-20%
Book Value Per Share5.38 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%0%100%200%300%400%500%
Cash Flow From Operations56.39 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%2,000%2,500%3,000%3,500%
Short Ratio18.75 X
Earnings Per Share0.66 X
Price To Earnings To Growth1.67 X
Target Price19.33
Number Of Employees3.5 K
Beta2.38
Market Capitalization698.19 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-311,000%2,000%3,000%4,000%
Total Asset590.41 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31200%400%600%800%1,000%
Retained Earnings150.28 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312,000%4,000%6,000%8,000%
Working Capital129.02 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Current Asset238.55 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%200%400%600%
Current Liabilities120.76 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31200%400%600%800%
Annual Yield0 %
Five Year Return2.66 %
Net Asset590.41 M
Last Dividend Paid0.04

About Core Laboratories Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Core Laboratories NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Core Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Core Laboratories NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Core Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Core Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Core Laboratories Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Core Laboratories Nv Stock:
Check out Core Laboratories Piotroski F Score and Core Laboratories Altman Z Score analysis.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Oil & Gas Equipment & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
2.896
Dividend Share
0.04
Earnings Share
0.66
Revenue Per Share
11.17
Quarterly Revenue Growth
0.008
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.


 

Discover investing ideas

Utilize additional investing modules

News Freq…Investor S…